Optical Brightening Agent OB-1 | CAS:1533-45-5

We serve Optical Brightening Agent OB-1 CAS:1533-45-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Optical Brightening Agent OB-1

Optical Brightening Agent OB-1
 
Main composition
Chemical name:2,2'-(1,2-Ethenediyldi-4, 1-phenylene)bisbenzoxazole
C.I.No:393
CAS:1533-45-5
Formula:C28H18N2O2
Molecular Weight:414.4
 
Technical index  
Appearance:Green- yellow powder
Melting Point:359℃
Purity:≥98.0%
Volatile:0.5%
 
Performance and Features  
1.High whiteness and strong fluorescence.
2.It has wide adaptability and is widely used in whitening of polyester, nylon fiber and various plastics.
3.Excellent heat resistance and light fastness.
Recommended dosage: the dosage of OB-1 against 1000kg material by weight.
1.For EVA, polypropylene, nylon and polycarbonate, add 75-200g.
2.For polyester fiber, add 75-300g.
 
Packaging and Storage  
Packaging with 25kg bag, 25kg carton, 500kg bag or according to customer's request.
Shelf-life:2 years, store under the room temperature. Avoid strong sunlight and wet environment.



Contact us for information like Optical Brightening Agent OB-1 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,2′-(1,2-Ethenediyldi-4, 1-phenylene)bisbenzoxazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,2′-(1,2-Ethenediyldi-4, 1-phenylene)bisbenzoxazole Use and application,Optical Brightening Agent OB-1 technical grade,usp/ep/jp grade.


Related News: Once they have decided how to make the compound, our staff in the production department manufacture a high quantity of APIs using the large reactors in our plant.3-UREIDOPROPYLTRIETHOXYSILANE manufacturer There are no reliable vaccines available to rid your body of a coronavirus.2-chloro-5-methylpyridin-3-amine supplier With the onset of the DMF system for APIs, the concentration of the API industry will further increase.2-Mercapto-3-Butanol vendor The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.